|
⚲
|
| Keyboard |
| Arch Venture Management LLC
✚
|
|
|---|---|
| CRD # | 158196 |
| SEC # | 802-75688 |
| CIK # | 0001274403 |
| AUM | |
| Employees | |
| Fees | |
| Minimum | |
| Phone | 773-380-6600 |
| Address | 8755 West Higgins Road Chicago, IL 60631-2176 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| MAZE Therapeutics Inc | 123.0 | ||
| Rapport Therapeutics Inc | 116.7 | ||
| VIR Biotechnology Inc | 115.7 | ||
| Erasca Inc | 114.7 | ||
| Beam Therapeutics Inc | 108.2 | ||
| Lyell Immunopharma Inc | 65.1 | ||
| 10X Genomics Inc | 4.6 | ||
| Gossamer Bio Inc | 2.6 | ||
| Homology Medicines Inc | 2.1 | ||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Arch Venture Fund XIII LP | [2025-03-28] | 3,309.7 M | |
| Offered $3,000,000,000 · Filed 2024-02-01 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $3,000,000,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Arch Venture Fund XII LP | [2023-03-29] | 2,810.0 M | 2,960.5 M |
| Offered $2,910,000,000 · Filed 2022-04-01 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $100,000,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Arch Venture Fund Xi LP | [2021-03-26] | 1,850.0 M | 1,645.1 M |
| Offered $1,850,000,000 · Filed 2021-01-28 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Not Applicable | ||||
| VC | Arch Venture Fund X LP | [2019-03-22] | 635.8 M | 493.4 M |
| Offered $675,000,000 · Filed 2019-10-25 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $39,250,000 · Duration More than one year · Revenue Not Applicable | ||||
| VC | Arch Venture Fund X Overage LP | [2019-03-22] | 635.8 M | 530.4 M |
| Offered $675,000,000 · Filed 2019-10-25 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $39,250,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Arch Venture Fund IX LP | [2017-03-23] | 408.4 M | 486.3 M |
| Offered $550,000,000 · Filed 2016-11-18 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $141,614,286 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Arch Venture Fund IX Overage LP | [2017-03-23] | 438.8 M | |
| Offered $450,000,000 · Filed 2016-11-18 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $450,000,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Arch Venture Fund VIII Overage LP | [2016-03-24] | 156.0 M | |
| Offered $150,000,000 · Filed 2015-03-06 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $150,000,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Arch Venture Fund VIII LP | [2015-03-26] | 400.5 M | 384.3 M |
| Offered $400,532,000 · Filed 2014-08-27 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $250,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Arch Entrepreneurs Fund LP | 2012-03-30 | 0.0 M | |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Discretionary | ||
| Discretionary | 0 | 0.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.0 | |
| Total | 0 | 0.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Mark McDonnell | Executive Officer | 16 | 3 | |
| Jason Doren | Executive Officer | 8 | 3 | |
| Steven Gillis | Executive Officer | 84 | 2 | |
| Robert Nelsen | Executive Officer | 71 | 2 | |
| Keith Crandell | Executive Officer | 63 | 2 | |
| Clinton Bybee | Executive Officer | 61 | 2 | |
| Kristina Burow | Executive Officer | 57 | 2 | |
| Paul Berns | Executive Officer | 16 | 2 | |
| Paul Thurk | Executive Officer | 5 | 1 | |
| Arch Venture Partners IX LLC | Director | 2 | 1 | |
| Arch Venture Partners VIII LLC | Director | 2 | 1 | |
| Arch Venture Partners X LLC | Director | 2 | 1 | |
| Arch Venture Partners XIII LLC | Director | 1 | 1 | |
| Arch Venture Partners XII LLC | Director | 1 | 1 | |
| Arch Venture Partners Xi LLC | Director | 1 | 1 | |
| Arch Venture Partners IX LP | Director | 1 | 1 | |
| Arch Venture Partners VIII LP | Director | 1 | 1 | |
| Arch Venture Partners X Overage LP | Director | 1 | 1 | |
| Arch Venture Partners Xi LP | Director | 1 | 1 | |
| Arch Venture Partners IX Overage LP | Director | 1 | 1 | |
| Arch Venture Partners XIII LP | Director | 1 | 1 | |
| Arch Venture Partners X LP | Director | 1 | 1 | |
| Arch Venture Partners XII LP | Director | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001274403] |